ARWR:NASDAQ
Arrowhead Pharmaceuticals Inc
$82.63
arrow_downward
-2.91%(-2.48) 1D
$81.08
arrow_downward
-1.88% (-1.55)bedtimeAfter hours
Closed: Sep 9, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARWR...
Open
$84.65
High
$87.20
Low
$82.16
Mkt. cap
11.67B
Avg. vol.
1.23M
Volume
0.00
52-wk high
$95.49
52-wk low
$27.80
EPS
-$2.24
Beta
1.28
Shares outstanding
141.25M
No. of employees
711
Open
$84.65
High
$87.20
Low
$82.16
Mkt. cap
11.67B
Avg. vol.
1.23M
Volume
0.00
52-wk high
$95.49
52-wk low
$27.80
EPS
-$2.24
Beta
1.28
Shares outstanding
141.25M
No. of employees
711
News stories
From web sources and news partners
Simply Wall Street
·
8 hours ago
How Investors May Respond To Arrowhead Stock Phase 3 Trial Results
Stock Traders Daily
·
16 hours ago
Avoiding Lag: Real-Time Signals in (ARWR) Movement
GuruFocus
·
18 hours ago
ARWR Looks 63.8% Overvalued on GF Valueâ„¢
Zacks Investment Research
·
1 day ago
ARWR: SHASTA-3 and SHASTA-4 Data Presented at ESC 2026
Profile
Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead's products in development act through RNA interference mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease. Wikipedia
About Arrowhead Pharmaceuticals Inc
CEOChristopher Richard Anzalone
Employees711
FoundedJan 1, 2004
HeadquartersPasadena, California, United States
SectorBiotechnology
Websitearrowheadpharma.com